Aurobindo has received the Food and Drug Administration’s stamp of approval for Colchicine tablets.
The product is the generic of Takeda’s Colcrys.
[Read more: Aurobindo obtains FDA OK for generic Lioresal]
The medication is indicated in adults and children 4 years old or older for treatment of familial Mediterranean fever.
Colchicine tablets have a market value of $111 million for the 12 months ending November 2021, according to IQVIA.
[Read more: Aurobindo obtains FDA nod for generic Tricor]